Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,520 shares at $142.12 ($627K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Scheduled sale ($627k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.12 | 1,280 | $182K | 29.0% |
| 2 | $142.12 | 1,280 | $182K | 29.0% |
| 3 | $134.19 | 980 | $132K | 21.0% |
| 4 | $134.19 | 980 | $132K | 21.0% |
| Total | $138.68 avg | 4,520 | $627K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |